Literature DB >> 19855269

High-sensitivity C-reactive protein and plaque composition in patients with stable angina pectoris: a virtual histology intravascular ultrasound study.

Takashi Kubo1, Yoshiki Matsuo, Yasushi Hayashi, Takashi Yamano, Takashi Tanimoto, Yasushi Ino, Hironori Kitabata, Shigeho Takarada, Kumiko Hirata, Atsushi Tanaka, Nobuo Nakamura, Masato Mizukoshi, Toshio Imanishi, Takashi Akasaka.   

Abstract

OBJECTIVE: Elevated high-sensitivity C-reactive protein (hs-CRP) is related to clinical outcome in coronary artery disease. We used virtual histology intravascular ultrasound to evaluate the relationship between serum hs-CRP level and coronary plaque composition in patients with stable angina pectoris. METHODS AND
RESULTS: Overall 113 consecutive patients with stable angina pectoris who had a de-novo culprit lesion were examined in this study. Patients were divided into an elevated hs-CRP group (>3 mg/l; n=40) or a normal hs-CRP group (n=73). Grayscale and virtual histology intravascular ultrasound analysis was performed across the entire culprit lesion. Mean plaque area was similar in both groups. Lesion length (18+/-5 vs. 16+/-6 mm, P<0.046) was significantly greater in the elevated hs-CRP group than that in the normal hs-CRP group. Although the percentage of dense calcium, fibrofatty tissue, and fibrous tissue was not different between the two groups, the percentage of necrotic core was significantly greater in the elevated hs-CRP group compared with the normal hs-CRP group (20+/-9 vs. 16+/-8%, P=0.014). The percentage of necrotic core was positively correlated with the serum hs-CRP level (r=0.20, P=0.037). A multivariate logistic regression model showed that the percentage of necrotic core was associated with elevated hs-CRP (P=0.019; odds ratio=1.1; 95% confidence interval=1.01-1.12).
CONCLUSION: Elevated hs-CRP was related to the amount of necrotic core in the culprit lesion of stable angina pectoris. Our results suggest that elevated hs-CRP might reflect the inflammatory activity of the coronary atherosclerotic plaque even in the setting of stable angina pectoris.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19855269     DOI: 10.1097/MCA.0b013e328332a6b0

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  9 in total

1.  Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems.

Authors:  Yoshiki Matsuo; Takuro Takumi; Verghese Mathew; Woo-Young Chung; Gregory W Barsness; Charanjit S Rihal; Rajiv Gulati; Eric T McCue; David R Holmes; Eric Eeckhout; Ryan J Lennon; Lilach O Lerman; Amir Lerman
Journal:  Atherosclerosis       Date:  2012-05-31       Impact factor: 5.162

2.  Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter.

Authors:  Hyo Eun Park; Heesun Lee; Su-Yeon Choi; Min-Sun Kwak; Jong In Yang; Jeong Yoon Yim; Goh Eun Chung
Journal:  J Gastroenterol       Date:  2018-10-04       Impact factor: 7.527

3.  Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography: relationship with serum inflammatory marker level.

Authors:  Xu Dai; Jianhong Deng; Mengmeng Yu; Zhigang Lu; Chengxing Shen; Jiayin Zhang
Journal:  Int J Cardiovasc Imaging       Date:  2020-01-06       Impact factor: 2.357

4.  Correlations between coronary plaque tissue composition assessed by virtual histology and blood levels of biomarkers for coronary artery disease.

Authors:  Young-Guk Ko; Van Cuong Le; Bo Hyun Kim; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

Review 5.  Clinical usefulness of novel serum and imaging biomarkers in risk stratification of patients with stable angina.

Authors:  George Tsaknis; Iraklis Tsangaris; Ignatios Ikonomidis; Argirios Tsantes
Journal:  Dis Markers       Date:  2014-06-19       Impact factor: 3.434

Review 6.  Clinical approach to the inflammatory etiology of cardiovascular diseases.

Authors:  Massimiliano Ruscica; Alberto Corsini; Nicola Ferri; Maciej Banach; Cesare R Sirtori
Journal:  Pharmacol Res       Date:  2020-05-20       Impact factor: 7.658

7.  Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease.

Authors:  Takayuki Ohwada; Takayuki Sakamoto; Yuki Kanno; Sayoko Yokokawa; Kazuaki Amami; Kazuhiko Nakazato; Yasuchika Takeishi; Kenichi Watanabe
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

8.  Circulating Microparticles and Coronary Plaque Components Assessed by Virtual Histology Intravascular Ultrasound of the Target Lesion in Patients with Stable Angina.

Authors:  Pil-Ki Min; Minhee Cho; Sung-Yu Hong; Jong-Youn Kim; Eui-Young Choi; Young-Won Yoon; Byoung Kwon Lee; Bum-Kee Hong; Se-Joong Rim; Hyuck Moon Kwon
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

9.  C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV.

Authors:  Adam J Nelson; Rishi Puri; Danielle M Brennan; Todd J Anderson; Leslie Cho; Christie M Ballantyne; John Jp Kastelein; Wolfgang Koenig; Helina Kassahun; Ransi M Somaratne; Scott M Wasserman; Steven E Nissen; Stephen J Nicholls
Journal:  Am J Prev Cardiol       Date:  2020-10-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.